{"name":"Pantarhei Bioscience","slug":"pantarhei-bioscience","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQMGxTd09yNTZDcFlQMzlRMm1oUHl6ci1xVUlnRzBIUnJTVjhFRDJqYmUyc0NYRXNNNkpaRTFCcTBVWGdUd1RDcVlETUdycnI0OXk5ZERXeVlHd3J4UnJHZ1pmRl8yNVBHUU9kSGVpSXpZYWo3enpKdWwyZGxEVVJxaUVJNGtHTE9lU2c?oc=5","date":"2021-07-02","type":"deal","source":"Generics and Biosimilars Initiative","summary":"Watson buys women’s health company Uteron - Generics and Biosimilars Initiative","headline":"Watson buys women’s health company Uteron","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5GanpVR0s5YWNwTGtVTFVvWnJOYXhQTFg1Rml6bDJxeEhmV2xsUE5OLVBmeXByRUt3RnhOTTIzYWNoQ3NWZ1JtZ2d3clFaZzNBRjluOFV6UVVEc05xQmc?oc=5","date":"2021-06-28","type":"pipeline","source":"ACS Publications","summary":"Synthesizing a natural product - ACS Publications","headline":"Synthesizing a natural product","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNajdVbVFka3FFaFRiRU1zWGswdnJ3aWRyOGZXMmxVV3VzeC1GQ3pnRVlISjg5SWprNUFGSHlCcGFSbDE4b3ZUZGpTOWowaHFaZl9CNTBZUnFsWncycXFUeU02X2ppZTg0Y29OT3JKLTFDNHpPNmZZZ200b3Vva19jNA?oc=5","date":"2011-03-08","type":"pipeline","source":"Pharmafile","summary":"Merck says sale of Oss facility would be too expensive - Pharmafile","headline":"Merck says sale of Oss facility would be too expensive","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}